These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4944335)

  • 1. [Preparation of purified sorbed botulinum toxoid type F. II. Activity of crude toxins and toxoids].
    Tsarapkin VP
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Nov; 48(11):105-8. PubMed ID: 4944335
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxoid of Clostridium botulinum type F: purification and immunogenicity studies.
    Hatheway CL
    Appl Environ Microbiol; 1976 Feb; 31(2):234-42. PubMed ID: 793522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preparation of purified shorbed botulinum toxoid type F. I. Comparative evaluation of different nutrient media for producing active type F botulinum toxin].
    Tsarapkin VP
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Oct; 48(10):28-31. PubMed ID: 4941812
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preparation of purified sorbed botulinum toxoid type F. 3. Purification, concentration and detoxification of toxin].
    Tsarapkin VP
    Zh Mikrobiol Epidemiol Immunobiol; 1972 Jan; 49(1):71-4. PubMed ID: 5010284
    [No Abstract]   [Full Text] [Related]  

  • 5. Clostridium botulinum type E toxin and toxoid.
    BARRON AL; REED GB
    Can J Microbiol; 1954 Oct; 1(2):108-17. PubMed ID: 14352045
    [No Abstract]   [Full Text] [Related]  

  • 6. Clostridium botulinum type B toxoids.
    RICE CE; SMITH LC
    Can J Res; 1947 Aug; 25(4):175-80. PubMed ID: 20264580
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on immunity to toxins of Clostridium botulinum. VIII. Immunological response of man to purified bivalent AB botulinum toxoid.
    FIOCK MA; DEVINE LF; GEARINGER NF; DUFF JT; WRIGHT GG; KADULL PJ
    J Immunol; 1962 Mar; 88():277-83. PubMed ID: 13893049
    [No Abstract]   [Full Text] [Related]  

  • 8. A study of Clostridium botulinum toxoid. II. Type B toxoid.
    VOROB'EV AA; VASIL'EV NN; ENICHEV VM; PATRIKEYEV GT; SHEVELEV VM; ZYBIN VD; KORNEV IS; ANAN'EVA EP
    Zh Mikrobiol Epidemiol Immunobiol; 1961; 32():1851-6. PubMed ID: 14040098
    [No Abstract]   [Full Text] [Related]  

  • 9. [THE EFFECT OF PRELIMINARY ADMINISTRATION OF TOXOID ON THE RESISTANCE OF MICE TO BOTULINUM TOXIN. (PRELIMINARY REPORT)].
    ZHUK LN
    Zh Mikrobiol Epidemiol Immunobiol; 1964 Jul; 41():39-42. PubMed ID: 14247222
    [No Abstract]   [Full Text] [Related]  

  • 10. [Toxoids of botulinum toxin type G].
    Puig de Centorbi ON; Ciccarelli AS; Giménez DF
    Rev Argent Microbiol; 1980; 12(1):10-7. PubMed ID: 6755549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinal toxin and toxoid as antigens.
    Heimach RC; Champion LA; Sugiyama H
    Proc Soc Exp Biol Med; 1970 Oct; 135(1):151-4. PubMed ID: 4920940
    [No Abstract]   [Full Text] [Related]  

  • 12. Antigenicity of Clostridium botulinum type-E formol toxoid.
    Kondo H; Kondo S; Murata R; Sakaguchi G
    Jpn J Med Sci Biol; 1969 Apr; 22(2):75-85. PubMed ID: 4899485
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on immunity to toxins of Clostridium botulinum. II. Production and purification of type B toxin for toxoid.
    DUFF JT; KLERER J; BIBLER RH; MOORE DE; GOTTFRIED C; WRIGHT GG
    J Bacteriol; 1957 May; 73(5):597-601. PubMed ID: 13428702
    [No Abstract]   [Full Text] [Related]  

  • 14. [STUDY OF BOTULINUM TOXOIDS. VI. TYPE D BOTULINUM TOXOID].
    VOROBEV AA; VASILEV NN; SHEVELEV VM; VORONOVA ZA; PETROVA EK; BAZHENOVA GA; ANDROSHCHUK SM
    Zh Mikrobiol Epidemiol Immunobiol; 1963 Sep; 40():87-92. PubMed ID: 14119975
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on immunity to toxins of Clostridium botulinum. IV. Production and purification of type C toxin for conversion to toxoid.
    CARDELLA MA; DUFF JT; GOTTFRIED C; BEGEL JS
    J Bacteriol; 1958 Mar; 75(3):360-5. PubMed ID: 13513612
    [No Abstract]   [Full Text] [Related]  

  • 16. [Preparation of purified, sorbed type F botulin toxoid. IV. Immunogenic and antigenic properties of purified, sorbed type F botulin toxoid].
    Tsarapkin VP; Mel'nikov VN; Khamzina SI
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Aug; (8):131-2. PubMed ID: 4450868
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of toxigenic Clostridium botulinum type E by enzyme immunoassay.
    Dezfulian M; Bartlett JG
    Diagn Microbiol Infect Dis; 1991; 14(1):11-5. PubMed ID: 2013205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new method for the large-scale production of high-titre botulinum formol-toxoid types C and D.
    STERNE M; WENTZEL LM
    J Immunol; 1950 Aug; 65(2):175-83. PubMed ID: 15436997
    [No Abstract]   [Full Text] [Related]  

  • 19. [Results of comparative experimental examinations of the therapeutic effect of antitoxin, formol toxoid and the combination of both on Cl. botulinum-(D)-toxin produced intoxication].
    KATIC RV
    Zentralbl Bakteriol Orig; 1956 Aug; 166(6):510-6. PubMed ID: 13361428
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on immunity to toxins of Clostridium botulinum. V. Detoxification of purified type A and type B toxins, and the antigenicity of univalent and bivalent aluminium phosphate adsorbed toxoids.
    WRIGHT GG; DUFF JT; FIOCK MA; DEVLIN HB; SODERSTROM RL
    J Immunol; 1960 Apr; 84():384-9. PubMed ID: 13846070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.